Livingston-based artificial limb maker said sales for the 2013 year will be £12.3 million

Artificial limb maker Touch Bionics is reporting full-year sales will be up 23 per cent on the previous year to £12.3 million.

The Livingston-based company, a 2003 NHS Scotland spin-out via Scottish Health Innovations Ltd (SHIL), had reported a 17 per cent rise in sales the previous year to break £10 million in sales for the first time.

Touch Bionics notes in an interim results announcement the rise in sales for the 2013 year was driven by the introduction of the "i-limb ultra revolution" prosthetic hand, which was launched in 2011.

Last year the company opened a new 4,000 sq.ft production facility in Newburgh, New York, which will serve as its primary location for the production of Livingskin – the company's range of silicone prostheses.

In the financial year the company also introduced mobile apps for its biosim prosthetic control software and i-limb, which enable clinicians and patients to program the features of an i-limb via a handheld mobile device.

Ian Stevens, chief executive of Touch Bionics, said: “We are pleased with our 2013 performance and are looking forward to continued growth in 2014.

“Patients have benefited from recent enhancements to our technologies, which can restore significant function and self esteem following the trauma of upper limb loss.”

Touch Bionics was founded by inventor David Gow and is funded and supported by Archangel Informal Investment and Scottish Enterprise.